Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

LEFKOTHEA Regulates Nuclear and Chloroplast mRNA Splicing in Plants.

Daras G, Rigas S, Alatzas A, Samiotaki M, Chatzopoulos D, Tsitsekian D, Papadaki V, Templalexis D, Banilas G, Athanasiadou AM, Kostourou V, Panayotou G, Hatzopoulos P.

Dev Cell. 2019 Aug 12. pii: S1534-5807(19)30630-6. doi: 10.1016/j.devcel.2019.07.024. [Epub ahead of print]

PMID:
31447263
2.

Tumor Angiogenesis Is Differentially Regulated by Phosphorylation of Endothelial Cell Focal Adhesion Kinase Tyrosines-397 and -861.

Pedrosa AR, Bodrug N, Gomez-Escudero J, Carter EP, Reynolds LE, Georgiou PN, Fernandez I, Lees DM, Kostourou V, Alexopoulou AN, Batista S, Tavora B, Serrels B, Parsons M, Iskratsch T, Hodivala-Dilke KM.

Cancer Res. 2019 Sep 1;79(17):4371-4386. doi: 10.1158/0008-5472.CAN-18-3934. Epub 2019 Jun 12.

PMID:
31189647
3.

Bioactivity of Epigallocatechin Gallate Nanoemulsions Evaluated in Mice Model.

Koutelidakis AE, Argyri K, Sevastou Z, Lamprinaki D, Panagopoulou E, Paximada E, Sali A, Papalazarou V, Mallouchos A, Evageliou V, Kostourou V, Mantala I, Kapsokefalou M.

J Med Food. 2017 Sep;20(9):923-931. doi: 10.1089/jmf.2016.0160. Epub 2017 Jul 24.

PMID:
28737454
4.

Endothelial FAK is required for tumour angiogenesis.

Tavora B, Batista S, Reynolds LE, Jadeja S, Robinson S, Kostourou V, Hart I, Fruttiger M, Parsons M, Hodivala-Dilke KM.

EMBO Mol Med. 2016 Oct 4;8(10):1229. doi: 10.15252/emmm.201606907. Print 2016 Oct. No abstract available.

5.

Angiotensin II inhibitor facilitates epidermal wound regeneration in diabetic mice.

Kamber M, Papalazarou V, Rouni G, Papageorgopoulou E, Papalois A, Kostourou V.

Front Physiol. 2015 Jun 9;6:170. doi: 10.3389/fphys.2015.00170. eCollection 2015.

6.

Generation of point-mutant FAK knockin mice.

Tavora B, Batista S, Alexopoulou AN, Kostourou V, Fernandez I, Robinson SD, Lees DM, Serrels B, Hodivala-Dilke K.

Genesis. 2014 Nov;52(11):907-15. doi: 10.1002/dvg.22823. Epub 2014 Sep 30.

PMID:
25242698
7.

ARF: a versatile DNA damage response ally at the crossroads of development and tumorigenesis.

Kotsinas A, Papanagnou P, Evangelou K, Trigas GC, Kostourou V, Townsend P, Gorgoulis VG.

Front Genet. 2014 Jul 22;5:236. doi: 10.3389/fgene.2014.00236. eCollection 2014.

8.

Non-collagenous ECM proteins in blood vessel morphogenesis and cancer.

Kostourou V, Papalazarou V.

Biochim Biophys Acta. 2014 Aug;1840(8):2403-13. doi: 10.1016/j.bbagen.2014.02.018. Epub 2014 Feb 24. Review.

PMID:
24576673
9.

FAK-heterozygous mice display enhanced tumour angiogenesis.

Kostourou V, Lechertier T, Reynolds LE, Lees DM, Baker M, Jones DT, Tavora B, Ramjaun AR, Birdsey GM, Robinson SD, Parsons M, Randi AM, Hart IR, Hodivala-Dilke K.

Nat Commun. 2013;4:2020. doi: 10.1038/ncomms3020.

10.

Interplay between oncogenic K-Ras and wild-type H-Ras in Caco2 cell transformation.

Ikonomou G, Kostourou V, Shirasawa S, Sasazuki T, Samiotaki M, Panayotou G.

J Proteomics. 2012 Sep 18;75(17):5356-69. doi: 10.1016/j.jprot.2012.06.038. Epub 2012 Jul 16.

PMID:
22800643
11.

Endothelial FAK is required for tumour angiogenesis.

Tavora B, Batista S, Reynolds LE, Jadeja S, Robinson S, Kostourou V, Hart I, Fruttiger M, Parsons M, Hodivala-Dilke KM.

EMBO Mol Med. 2010 Dec;2(12):516-28. doi: 10.1002/emmm.201000106. Erratum in: EMBO Mol Med. 2016 Oct 4;8(10 ):1229.

12.

The role of tumour-derived iNOS in tumour progression and angiogenesis.

Kostourou V, Cartwright JE, Johnstone AP, Boult JK, Cullis ER, Whitley G, Robinson SP.

Br J Cancer. 2011 Jan 4;104(1):83-90. doi: 10.1038/sj.bjc.6606034. Epub 2010 Dec 7.

13.

Endothelial cell talin1 is essential for embryonic angiogenesis.

Monkley SJ, Kostourou V, Spence L, Petrich B, Coleman S, Ginsberg MH, Pritchard CA, Critchley DR.

Dev Biol. 2011 Jan 15;349(2):494-502. doi: 10.1016/j.ydbio.2010.11.010. Epub 2010 Nov 26.

14.

Endothelial alpha3beta1-integrin represses pathological angiogenesis and sustains endothelial-VEGF.

da Silva RG, Tavora B, Robinson SD, Reynolds LE, Szekeres C, Lamar J, Batista S, Kostourou V, Germain MA, Reynolds AR, Jones DT, Watson AR, Jones JL, Harris A, Hart IR, Iruela-Arispe ML, Dipersio CM, Kreidberg JA, Hodivala-Dilke KM.

Am J Pathol. 2010 Sep;177(3):1534-48. doi: 10.2353/ajpath.2010.100043. Epub 2010 Jul 16.

15.

TAF4b and Jun/activating protein-1 collaborate to regulate the expression of integrin alpha6 and cancer cell migration properties.

Kalogeropoulou M, Voulgari A, Kostourou V, Sandaltzopoulos R, Dikstein R, Davidson I, Tora L, Pintzas A.

Mol Cancer Res. 2010 Apr;8(4):554-68. doi: 10.1158/1541-7786.MCR-09-0159. Epub 2010 Mar 30.

16.

Genetic ablation of the alpha 6-integrin subunit in Tie1Cre mice enhances tumour angiogenesis.

Germain M, De Arcangelis A, Robinson SD, Baker M, Tavora B, D'Amico G, Silva R, Kostourou V, Reynolds LE, Watson A, Jones JL, Georges-Labouesse E, Hodivala-Dilke K.

J Pathol. 2010 Feb;220(3):370-81. doi: 10.1002/path.2654.

PMID:
19967723
17.

Regulation of lymphatic-blood vessel separation by endothelial Rac1.

D'Amico G, Jones DT, Nye E, Sapienza K, Ramjuan AR, Reynolds LE, Robinson SD, Kostourou V, Martinez D, Aubyn D, Grose R, Thomas GJ, Spencer-Dene B, Zicha D, Davies D, Tybulewicz V, Hodivala-Dilke KM.

Development. 2009 Dec;136(23):4043-53. doi: 10.1242/dev.035014. Erratum in: Development. 2010 Jan;137(2):359.

18.

Alphav beta3 integrin limits the contribution of neuropilin-1 to vascular endothelial growth factor-induced angiogenesis.

Robinson SD, Reynolds LE, Kostourou V, Reynolds AR, da Silva RG, Tavora B, Baker M, Marshall JF, Hodivala-Dilke KM.

J Biol Chem. 2009 Dec 4;284(49):33966-81. doi: 10.1074/jbc.M109.030700. Epub 2009 Oct 16.

19.

Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors.

Reynolds AR, Hart IR, Watson AR, Welti JC, Silva RG, Robinson SD, Da Violante G, Gourlaouen M, Salih M, Jones MC, Jones DT, Saunders G, Kostourou V, Perron-Sierra F, Norman JC, Tucker GC, Hodivala-Dilke KM.

Nat Med. 2009 Apr;15(4):392-400. doi: 10.1038/nm.1941. Epub 2009 Mar 22.

PMID:
19305413
20.

Efficient, inducible Cre-recombinase activation in vascular endothelium.

Claxton S, Kostourou V, Jadeja S, Chambon P, Hodivala-Dilke K, Fruttiger M.

Genesis. 2008 Feb;46(2):74-80. doi: 10.1002/dvg.20367.

PMID:
18257043
21.

Overexpression of dimethylarginine dimethylaminohydrolase enhances tumor hypoxia: an insight into the relationship of hypoxia and angiogenesis in vivo.

Kostourou V, Troy H, Murray JF, Cullis ER, Whitley GS, Griffiths JR, Robinson SP.

Neoplasia. 2004 Jul-Aug;6(4):401-11.

22.

A direct functional link between the multi-PDZ domain protein GRIP1 and the Fraser syndrome protein Fras1.

Takamiya K, Kostourou V, Adams S, Jadeja S, Chalepakis G, Scambler PJ, Huganir RL, Adams RH.

Nat Genet. 2004 Feb;36(2):172-7. Epub 2004 Jan 18.

PMID:
14730302
23.
24.

Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis.

Kostourou V, Robinson SP, Cartwright JE, Whitley GS.

Br J Cancer. 2002 Sep 9;87(6):673-80.

25.

RNA polymerase subunit H features a beta-ribbon motif within a novel fold that is present in archaea and eukaryotes.

Thiru A, Hodach M, Eloranta JJ, Kostourou V, Weinzierl RO, Matthews S.

J Mol Biol. 1999 Apr 9;287(4):753-60.

PMID:
10191143

Supplemental Content

Loading ...
Support Center